PMID: 6165509Jan 1, 1980Paper

Seven cases of Huntington's disease in childhood and levodopa induced improvement in the hypokinetic--rigid form

Clinical Neurology and Neurosurgery
P J JongenF J Gabreëls

Abstract

Seven cases of the infantile form of Huntington's disease--six boys and one girl--were observed in the space of six years. Six children showed the hypokinetic-rigid form of the disease. Results of clinical, speech evaluations, laboratory tests, EEG and LPEG corresponded with data in literature. Initial signs and symptoms were mild sensorimotor and behavioural disturbances. In five patients, all affected by the hypokinetic-rigid form, CSF HVA and 5HIAA were determined. CSF HVA levels were found to be significantly lowered in three patients. One child showed significant decrease of CSF 5HIAA. Levodopa, orally administrated to these five patients during 8 days to 6 weeks in dosages of 75 to 600 mg per day, induced in all a marked improvement of the hypokinesia and/or rigidity, speech and social behaviour. Two children developed slight choreatic movements and one child had to be withdrawn from the drug because of decrease of appetite.

References

Jul 1, 1975·Journal of Neurology, Neurosurgery, and Psychiatry·S M AquiloniusA Sundwall
Oct 1, 1976·Journal of Neurology, Neurosurgery, and Psychiatry·C LoebC Albano
Jun 1, 1977·Journal of Neurology, Neurosurgery, and Psychiatry·T CaraceniP L Morselli
Jun 1, 1987·The British Journal of Psychiatry : the Journal of Mental Science·H Roberts
Apr 22, 1972·Lancet·B K TanH J v d Brand
Mar 2, 1974·Lancet·G Schenk, H J Leijnse-Ybema
Feb 13, 1969·The New England Journal of Medicine·G C CotziasR Gellene
Aug 1, 1972·Journal of Neurology, Neurosurgery, and Psychiatry·G CurzonD Sharpe
Feb 28, 1973·Clinica Chimica Acta; International Journal of Clinical Chemistry·C M YatesI A Pullar
Jan 1, 1973·Postgraduate Medical Journal·K W Heathfield
Sep 1, 1974·Neurology·W L Stahl, P D Swanson
Feb 15, 1973·The New England Journal of Medicine·T L PerryM Kloster
Jan 1, 1981·Acta Neuropathologica·G T Bots, G W Bruyn
Sep 1, 1963·Archives of Neurology·G A JERVIS
Dec 1, 1966·Journal of Medical Genetics·N C Myrianthopoulos

❮ Previous
Next ❯

Citations

Jul 1, 1986·Human Genetics·J G van DijkG W Bruyn
Feb 9, 2012·Current Treatment Options in Neurology·Annie Killoran, Kevin M Biglan
May 1, 1996·Clinical Neurology and Neurosurgery·G HagemanA R Rozeboom
Jul 1, 1983·Annals of Human Genetics·L N WentW S Volkers
Jan 15, 2014·Neurodegenerative Disease Management·Oliver W J QuarrellFerdinando Squitieri
Apr 8, 2014·Journal of Neurosurgery·Victoria GonzalezPhilippe Coubes
Nov 30, 2014·Neurologic Clinics·Praveen Dayalu, Roger L Albin
May 21, 2009·Expert Opinion on Emerging Drugs·Sarah L Mason, Roger A Barker
Dec 5, 2000·Movement Disorders : Official Journal of the Movement Disorder Society·E CuboJ S Kroin
Aug 29, 2014·Movement Disorders : Official Journal of the Movement Disorder Society·Annie Killoran, Kevin M Biglan
Jun 27, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Wendy PhillipsRoger A Barker
May 20, 1998·Aging : Clinical and Experimental Research·A CherubiniU Senin
May 6, 2014·Frontiers in Behavioral Neuroscience·Patrick PlaSandrine Humbert
Mar 23, 2017·Current Neurology and Neuroscience Reports·Kara J WyantPraveen Dayalu
Feb 1, 1989·Developmental Medicine and Child Neurology·P M van ErvenM W Horstink
Sep 1, 1990·Clinical Genetics·D J Clarke, S Bundey
Jul 25, 2019·Frontiers in Neurology·Anne-Catherine Bachoud-LéviJean-Marc Burgunder
Aug 27, 2016·Revue neurologique·G DésaméricqA-C Bachoud-Lévi
Feb 1, 1984·Annals of Neurology·O BugianiS Cammarata

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.